| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.63 | 0.01 |